LPL Financial
RVMD icon

LPL Financial’s Revolution Medicines RVMD Stock Holding History

LPL Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Buy
22,619
+6,832
+43% +$690K ﹤0.01% 3416
2025
Q4 		$1.26M Buy
15,787
+9,928
+169% +$651K ﹤0.01% 3832
2025
Q3 		$274K Buy
+5,859
New +$229K ﹤0.01% 5123
2025
Q1 		– Sell
-10,318
Closed -$451K – 5488
2024
Q4 		$451K Sell
10,318
-4,212
-29% -$213K ﹤0.01% 4188
2024
Q3 		$659K Buy
14,530
+8,418
+138% +$367K ﹤0.01% 3768
2024
Q2 		$237K Buy
+6,112
New +$228K ﹤0.01% 4438

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPL Financial's RVMD Position: Q1 2026 in Review

LPL Financial increased its Revolution Medicines (RVMD) stake by 43% in Q1 2026, buying an estimated $690K and bringing the position to 22,619 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3416.

LPL Financial first reported a position in RVMD in Q2 2024 and has held it in 6 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • LPL Financial held 22,619 shares of Revolution Medicines worth $2.2M as of Q1 2026.
  • LPL Financial bought 6,832 Revolution Medicines shares in Q1 2026, an estimated $690K.
  • Revolution Medicines made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #3416 holding.
  • LPL Financial first reported a position in Revolution Medicines in Q2 2024 and has held it in 6 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.